Dublin, Nov. 11, 2024 (GLOBE NEWSWIRE) — The “Computational Biology Market Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering.
The global computational biology market was valued at USD 5.25 billion in 2023 driven by increasing investments in computational biology research and the rising interdisciplinary collaborations across the globe. The market is further expected to grow at a CAGR of 14.1% in the forecast period of 2024-2032 to attain a value of over USD 19.63 billion by 2032.
Market Drivers
- Technological Advancements: Continuous developments in high-throughput sequencing technologies, bioinformatics tools, and computational power have significantly enhanced the capabilities of computational biology. These advancements allow for more accurate modelling and analysis of complex biological systems.
- Rising Investment in Healthcare and Research: Increasing investments from both governmental and private entities in healthcare infrastructure, genomic research, and personalised medicine are major drivers. Funding initiatives and grants aimed at fostering innovation in computational biology are contributing to market growth.
- Growing Demand for Personalised Medicine: The shift towards personalised medicine, which tailors medical treatment to individual characteristics, is heavily reliant on computational biology. The ability to analyse genetic data and predict responses to treatments is driving demand for computational biology solutions.
- Expansion of Big Data in Biology: The proliferation of biological data from various sources such as genomic studies, clinical trials, and research projects necessitates advanced computational tools for data integration, analysis, and interpretation.
Challenges
- Data Complexity and Management: The sheer volume and complexity of biological data pose significant challenges. Efficiently managing, storing, and analysing this data requires sophisticated algorithms and computational infrastructure, which can be resource-intensive.
- Interdisciplinary Skill Requirements: The field of computational biology demands expertise across multiple disciplines, including biology, mathematics, and computer science. The scarcity of professionals with such interdisciplinary skills can hinder the growth of the market.
- Ethical and Privacy Concerns: The use of personal genetic information in computational biology raises ethical and privacy concerns. Ensuring data security and addressing ethical issues related to data use and sharing are critical challenges that need to be addressed.
- Regulatory Hurdles: The regulatory environment for computational biology can be complex, with varying standards and requirements across different regions. Navigating these regulatory frameworks can be challenging for companies operating in this space.
Future Opportunities
- Integration with Artificial Intelligence: The integration of artificial intelligence (AI) and machine learning (ML) with computational biology offers significant opportunities. AI and ML can enhance data analysis, improve predictive modelling, and accelerate drug discovery processes.
- Advancements in Genomics and Proteomics: Continued advancements in genomics and proteomics are expected to drive the need for computational biology solutions. The ability to decode and analyse genetic and protein data will open new avenues for research and development in personalised medicine and therapeutic interventions.
- Collaboration and Partnerships: Increasing collaboration between academic institutions, research organisations, and industry players can foster innovation and drive market growth. Partnerships can lead to the development of novel computational tools and methodologies.
- Expansion into Emerging Markets: The computational biology market has significant growth potential in emerging markets. Increasing investment in healthcare infrastructure and research in regions such as Asia-Pacific and Latin America can provide new opportunities for market expansion.
- Focus on Rare Diseases: Computational biology has the potential to make significant contributions to the understanding and treatment of rare diseases. By leveraging computational models to study the underlying mechanisms of rare diseases, researchers can identify new therapeutic targets and develop effective treatments.
Global Computational Biology Market Segmentation
The computational biology market, segmented by services, includes on-premises and cloud-based solutions. On-premises services are driven by the need for data security and control, while cloud-based services are propelled by scalability, collaboration, and real-time data analysis. The future growth of the market is expected to be dominated by cloud-based solutions due to their cost-effectiveness and flexibility. This segment is poised to drive market growth during the forecast period by enabling broader accessibility to advanced computational tools, fostering innovation, and supporting the increasing demand for personalised medicine and large-scale biological data analysis.
The computational biology market, segmented by application, includes genomics and genetics, drug discovery and development, and others. Genomics and genetics are driven by advances in sequencing technologies and the growing need for personalised medicine. Drug discovery and development benefit from computational tools that accelerate target identification and reduce costs. The category includes diverse applications like proteomics and system biology. Future growth is expected to be strong in genomics and drug discovery, driven by technological advancements and increased R&D investments. These segments are poised to propel market growth by enhancing precision medicine and expediting the drug development process.
The computational biology market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America leads the market due to substantial investments in R&D, advanced healthcare infrastructure, and the presence of key industry players. Europe follows with robust funding for biotechnology and personalised medicine initiatives. The Asia Pacific region is experiencing rapid growth, driven by increasing government support, rising healthcare expenditure, and expanding biotech industries. Latin America and the Middle East and Africa are also witnessing growth due to improving healthcare infrastructure and growing awareness. These regions are collectively driving market expansion by fostering innovation and broadening access to computational biology technologies.
Global Computational biology Market Competitive Landscape
The computational biology market features prominent players such as Chemical Computing Group, Dassault Systemes S.E., Certara, Inc., Instem plc, Compugen, Genedata, Yokogawa Denki Kabushiki Kaisha, Strand Life Sciences Private Limited, Schrodinger, Inc., and SimulationPlus. These companies are actively engaged in mergers and acquisitions, enhancing their market position and technological capabilities. They are also involved in significant research initiatives, driving innovation and advancements in computational biology.
Product introductions and the development of advanced computational tools are common, catering to the growing demands of personalised medicine and drug discovery. Strategic partnerships and collaborations with research institutions and other industry players are prevalent, fostering knowledge exchange and expanding their market reach. These activities collectively contribute to the dynamic and competitive landscape of the computational biology market.
Reasons to consider this report:
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global computational biology market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the computational biology market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter’s five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global computational biology industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2024-2032 |
| Estimated Market Value (USD) in 2024 | $6.83 Billion |
| Forecasted Market Value (USD) by 2032 | $19.63 Billion |
| Compound Annual Growth Rate | 14.1% |
| Regions Covered | Global |
Key Topics Covered
1 Preface
2 Executive Summary
3 Global Computational Biology Market Overview
4 Vendor Positioning Analysis
5 Global Computational Biology Market Landscape
6 Global Computational Biology Market Dynamics
7 Global Computational Biology Market Segmentation (2017-2032)
8 North America Computational Biology Market (2017-2032)
9 Europe Computational Biology Market (2017-2032)
10 Asia Pacific Computational Biology Market (2017-2032)
11 Latin America Computational Biology Market (2017-2032)
12 Middle East and Africa Computational Biology Market (2017-2032)
13 Funding and Investment Analysis
14 Strategic Initiatives
15 Supplier Landscape
16 Global Computational Biology Market – Distribution Model
17 Key Opinion Leaders (KOL) Insights
For more information about this report visit https://www.researchandmarkets.com/r/lm35uw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Computational Biology Market
